MedPath

Pelvic Floor and Sexual Dysfunction in Women with Sjogren's Syndrome

Completed
Conditions
Pelvic Organ Prolapse
Urinary Incontinence
Pelvic Floor Disorders
Sexual Dysfunction
Constipation
Registration Number
NCT04415710
Lead Sponsor
Akdeniz University
Brief Summary

Sjogren's syndrome (SS) is a chronic, systemic, autoimmune disease characterized by lymphocytic infiltration of all exocrine glands, especially tear and salivary glands, and is more common in women.

Detailed Description

Sexual functions are affected by symptoms such as pain, fatigue, stiffness, and hormonal imbalance in rheumatological disorders. Vaginal dryness and dyspepsia negatively affect participation in sexual activity. The aim of the study is to examine the pelvic floor problems of women with SS with a self-report, to compare them with healthy individuals, and finally to examine the relationship between pelvic floor problems and sexual dysfunction.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
94
Inclusion Criteria
  • being between the ages of 18-65
  • being a woman,
  • having sex partner,
  • no smoking, no alcohol
Exclusion Criteria
  • physical, psychological, cognitive impairment,
  • having a non-Sjögren additional disease,
  • malignancy,
  • pregnancy,
  • no urogenital disease,
  • sarcoidosis,
  • AIDS,
  • anticholinergic drug use,
  • had a gynecological or urological operation other than cesarean

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pelvic Floor Distress Inventory PFDI-201 week

Pelvic Floor Distress Inventory has a total of 20 questions and 3 scales (Urinary Distress Inventory, Pelvic Organ Prolapse Distress Inventory, and Colorectal-Anal Distress Inventory). Each short-form scale demonstrates significant correlation with their long-form scales

Pelvic Floor Impact Questionnaire PFIQ1 week

Pelvic Floor Impact Questionnaire (PFIQ): The questionnaire has 7 questions and each question has 3 separate responses. The response to each item of satisfaction, impact and worry was rated from 3 (quite a bit) to 0 (not at all) for the PFIQ-7. The mean value for all the answered items within the corresponding scale (possible value 0-3) was estimated, then multiplied by (100/3) to obtain the scale score, range 0-100.

Female Sexual Dysfunction Index FSFI1 week

The FSFI is a brief questionnaire measure of sexual functioning in women. It was developed for the specific purpose of assessing domains of sexual functioning (e.g. sexual arousal, orgasm, satisfaction, pain) in clinical trials.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ayse Ayan

🇹🇷

Antalya, Turkey

© Copyright 2025. All Rights Reserved by MedPath